Tolvaptan PK/PD Study of QD formulations in Healthy Subjects QSC204665

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  297616

• Contact name

  Nataliya Agafonova

• Contact email

  nataliya.agafonova@otsuka-us.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2021-001405-79

• Duration of Study in the UK

  0 years, 3 months, 15 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  21/LO/0431

• Date of REC Opinion

  14 Jun 2021

• REC opinion

  Favourable Opinion